Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Other Working Capital Changes (2017 - 2025)

Dare Bioscience (DARE) has disclosed Other Working Capital Changes for 10 consecutive years, with -$287918.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes fell 111.05% year-over-year to -$287918.0, compared with a TTM value of -$4.2 million through Sep 2025, down 514.54%, and an annual FY2024 reading of -$3.6 million, down 492.97% over the prior year.
  • Other Working Capital Changes was -$287918.0 for Q3 2025 at Dare Bioscience, down from -$134909.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.3 million in Q4 2022 and bottomed at -$3.6 million in Q4 2024.
  • Average Other Working Capital Changes over 5 years is $92624.9, with a median of -$120802.0 recorded in 2024.
  • The sharpest move saw Other Working Capital Changes surged 10899.77% in 2022, then crashed 1621.47% in 2024.
  • Year by year, Other Working Capital Changes stood at -$39513.0 in 2021, then soared by 10899.77% to $4.3 million in 2022, then crashed by 76.52% to $1.0 million in 2023, then crashed by 459.22% to -$3.6 million in 2024, then skyrocketed by 92.0% to -$287918.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for DARE at -$287918.0 in Q3 2025, -$134909.0 in Q2 2025, and -$131429.0 in Q1 2025.